HOUSTON, TX--(Marketwired - Apr 14, 2015) - Nobilis Health Corp. (
Pursuant to the terms of the Private Placement, the expiry of the Warrants may be accelerated at any time prior to the expiry of the Warrants if the ten day volume weighted average price of the Company's common shares on the Toronto Stock Exchange is CAD $2.20 or higher, at which time the Company may give notice in writing (the "Early Expiry Notice") to the Warrant holders that the Warrants will expire on the date that is thirty (30) calendar days after the date of the Early Expiry Notice.
A Notice of Acceleration dated April 14, 2015 will be sent to the holders of the Warrants issued pursuant to the Private Placement to advise that the expiry date of the Warrants is being accelerated to 5:00 p.m. (Vancouver time) on May 14, 2015. Any Warrants remaining unexercised after May 14, 2015 will expire without any further action being taken.
Originally 2,784,200 Warrants were issued on September 26, 2014. As of this date 1,378,859 of the Warrants have already been exercised.
About Nobilis Health Corp.
Nobilis utilizes innovative direct-to-patient marketing focused on a specified set of procedures that are performed at our centers by local physicians. We own and manage ambulatory and acute care facilities to deliver healthcare services. Nobilis owns and manages interests in ambulatory surgery centers in Houston, Dallas, and Scottsdale, Arizona. In addition, Nobilis owns one acute care hospital in Houston. Nobilis also owns and manages interests in two imaging centers and one urgent care clinic in Houston.
Forward-looking statements
This news release may contain forward-looking statements (within the meaning of applicable securities laws) and financial outlooks relating to the business of Nobilis Health Corp. (the "Company") and the environment in which it operates. Forward-looking statements are identified by words such as "believe", "anticipate", "expect", "intend", "plan", "will", "may" and other similar expressions and may discuss future expectations, contain projections of future results of operations or of financial condition, or state other forward-looking information. These statements are based on the Company's expectations, estimates, forecasts and projections and while the Company considers these to be reasonable based on information currently available, they may prove to be incorrect. They are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. These risks and uncertainties are discussed in the Company's regulatory filings available on the Company's web site at www.NobilisHealth.com, www.Sedar.com and in the risk factors described in the Company's Form 10-K for the fiscal year ended December 31, 2014, filed on April 2, 2015. There can be no assurance that forward-looking statements will prove to be accurate as actual outcomes and results may differ materially from those expressed in these forward-looking statements. Readers, therefore, should not place undue reliance on any such forward-looking statements. Further, a forward-looking statement speaks only as of the date on which such statement is made. Other than as required by law, the Company undertakes no obligation to publicly update any such statement or to reflect new information or the occurrence of future events or circumstances.